WealthPLAN Partners’s Gilead Sciences GILD Stock Holding History

WealthPLAN Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$303K	Buy	2,401 +550	+30%	+$72.5K	0.06%	188
2026 Q1	$258K	Buy	+1,851	New	+$259K	0.05%	203
2024 Q2	–	Sell	-9,810	Closed	-$719K	–	312
2024 Q1	$719K	Buy	+9,810	New	+$754K	0.07%	170
2023 Q3	–	Sell	-1,207	Closed	-$93K	–	619
2023 Q2	$93K	Sell	1,207 -15	-1%	-$1.2K	0.01%	412
2023 Q1	$101K	Buy	+1,222	New	+$101K	0.01%	422
2020 Q3	–	Sell	-3,303	Closed	-$225K	–	324
2020 Q2	$225K	Buy	3,303 +36	+1%	+$2.76K	0.02%	276
2020 Q1	$252K	Buy	+3,267	New	+$226K	0.03%	215
2017 Q2	–	Sell	-297	Closed	-$19.7K	–	272
2017 Q1	$19.7K	Buy	+297	New	+$20.9K	0.07%	190
2016 Q3	$1.8M	Sell	23,326 -16,600	-42%	-$1.35M	0.59%	35
2016 Q2	$1.67M	Buy	+39,926	New	+$3.54M	0.21%	80
2015 Q4	$911K	Buy	+31,126	New	+$3.24M	0.15%	109
2015 Q2	$604K	Buy	5,157 +1,523	+42%	+$166K	0.26%	53
2015 Q1	$357K	Buy	+3,634	New	+$369K	0.17%	86

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WealthPLAN Partners's GILD Position: Q2 2026 in Review

WealthPLAN Partners increased its Gilead Sciences (GILD) stake by 30% in Q2 2026, buying an estimated $72.5K and bringing the position to 2,401 shares worth $303K. The position accounts for 0.06% of the portfolio, ranked #188.

WealthPLAN Partners first reported a position in GILD in Q1 2015 and has held it in 13 quarters since. The position peaked at $1.8M in Q3 2016. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

WealthPLAN Partners held 2,401 shares of Gilead Sciences worth $303K as of Q2 2026.
WealthPLAN Partners bought 550 Gilead Sciences shares in Q2 2026, an estimated $72.5K.
Gilead Sciences made up 0.06% of WealthPLAN Partners's portfolio in Q2 2026, its #188 holding.
WealthPLAN Partners first reported a position in Gilead Sciences in Q1 2015 and has held it in 13 quarters since.
WealthPLAN Partners's Gilead Sciences position peaked at $1.8M in Q3 2016.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on WealthPLAN Partners's 13F filing for Q2 2026, filed 28 Jul 2026.